TY - JOUR AU - Shin, H. C. AU - Han, W. AU - Moon, H. G. AU - Im, S. A. AU - Moon, W. K. AU - Park, I. A. PY - 2013 DA - 2013// TI - Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients JO - Ann Surg Oncol VL - 20 UR - https://doi.org/10.1245/s10434-013-2909-6 DO - 10.1245/s10434-013-2909-6 ID - Shin2013 ER - TY - JOUR AU - Schott, A. F. AU - Hayes, D. F. PY - 2012 DA - 2012// TI - Defining the benefits of neoadjuvant chemotherapy for breast cancer JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.41.3161 DO - 10.1200/JCO.2011.41.3161 ID - Schott2012 ER - TY - JOUR AU - Bear, H. D. AU - Anderson, S. AU - Smith, R. E. AU - Geyer, C. E. AU - Mamounas, E. P. AU - Fisher, B. PY - 2006 DA - 2006// TI - Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.04.1665 DO - 10.1200/JCO.2005.04.1665 ID - Bear2006 ER - TY - JOUR AU - Buchholz, T. A. AU - Lehman, C. D. AU - Harris, J. R. AU - Pockaj, B. A. AU - Khouri, N. AU - Hylton, N. F. PY - 2008 DA - 2008// TI - Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.0326 DO - 10.1200/JCO.2007.15.0326 ID - Buchholz2008 ER - TY - JOUR AU - Esserman, L. J. AU - Berry, D. A. AU - DeMichele, A. AU - Carey, L. AU - Davis, S. E. AU - Buxton, M. PY - 2012 DA - 2012// TI - Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657 JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.39.2779 DO - 10.1200/JCO.2011.39.2779 ID - Esserman2012 ER - TY - JOUR AU - Symmans, W. F. AU - Peintinger, F. AU - Hatzis, C. AU - Rajan, R. AU - Kuerer, H. AU - Valero, V. PY - 2007 DA - 2007// TI - Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2007.10.6823 DO - 10.1200/JCO.2007.10.6823 ID - Symmans2007 ER - TY - JOUR AU - Esserman, L. J. AU - Berry, D. A. AU - Cheang, M. C. AU - Yau, C. AU - Perou, C. M. AU - Carey, L. PY - 2012 DA - 2012// TI - Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) JO - Breast Cancer Res Treat VL - 132 UR - https://doi.org/10.1007/s10549-011-1895-2 DO - 10.1007/s10549-011-1895-2 ID - Esserman2012 ER - TY - JOUR AU - Gonzalez-Angulo, A. M. AU - Iwamoto, T. AU - Liu, S. AU - Chen, H. AU - Do, K. A. AU - Hortobagyi, G. N. PY - 2012 DA - 2012// TI - Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2762 DO - 10.1158/1078-0432.CCR-11-2762 ID - Gonzalez-Angulo2012 ER - TY - JOUR AU - O’Regan, R. M. AU - Roenn, J. H. AU - Carlson, R. W. AU - Malik, U. AU - Sparano, J. A. AU - Staradub, V. PY - 2005 DA - 2005// TI - Final results of a phase II trial of preoperative TAC (docetaxel/doxorubicin/cyclophosphamide) in stage III breast cancer JO - Clin Breast Cancer VL - 6 UR - https://doi.org/10.3816/CBC.2005.n.019 DO - 10.3816/CBC.2005.n.019 ID - O’Regan2005 ER - TY - JOUR AU - Stearns, V. AU - Singh, B. AU - Tsangaris, T. AU - Crawford, J. G. AU - Novielli, A. AU - Ellis, M. J. PY - 2003 DA - 2003// TI - A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer JO - Clin Cancer Res VL - 9 ID - Stearns2003 ER - TY - JOUR AU - Hannemann, J. AU - Oosterkamp, H. M. AU - Bosch, C. A. AU - Velds, A. AU - Wessels, L. F. AU - Loo, C. PY - 2005 DA - 2005// TI - Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.09.077 DO - 10.1200/JCO.2005.09.077 ID - Hannemann2005 ER - TY - JOUR AU - Ferriere, J. P. AU - Assier, I. AU - Cure, H. AU - Charrier, S. AU - Kwiatkowski, F. AU - Achard, J. L. PY - 1998 DA - 1998// TI - Primary chemotherapy in breast cancer: correlation between tumor response and patient outcome JO - Am J Clin Oncol VL - 21 UR - https://doi.org/10.1097/00000421-199804000-00003 DO - 10.1097/00000421-199804000-00003 ID - Ferriere1998 ER - TY - JOUR AU - Pierga, J. Y. AU - Mouret, E. AU - Laurence, V. AU - Dieras, V. AU - Savigioni, A. AU - Beuzeboc, P. PY - 2003 DA - 2003// TI - Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer: the role of clinical response JO - Eur J Cancer VL - 39 UR - https://doi.org/10.1016/S0959-8049(03)00069-8 DO - 10.1016/S0959-8049(03)00069-8 ID - Pierga2003 ER - TY - JOUR AU - Hess, K. R. AU - Anderson, K. AU - Symmans, W. F. AU - Valero, V. AU - Ibrahim, N. AU - Mejia, J. A. PY - 2006 DA - 2006// TI - Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.05.6861 DO - 10.1200/JCO.2006.05.6861 ID - Hess2006 ER - TY - JOUR AU - Cortazar, P. AU - Zhang, L. AU - Untch, M. AU - Mehta, K. AU - Costantino, J. P. AU - Wolmark, N. PY - 2014 DA - 2014// TI - Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis JO - Lancet VL - 384 UR - https://doi.org/10.1016/S0140-6736(13)62422-8 DO - 10.1016/S0140-6736(13)62422-8 ID - Cortazar2014 ER - TY - JOUR AU - Sørlie, T. AU - Perou, C. M. AU - Fan, C. AU - Geisler, S. AU - Aas, T. AU - Nobel, A. PY - 2006 DA - 2006// TI - Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer JO - Mol Cancer Ther VL - 5 UR - https://doi.org/10.1158/1535-7163.MCT-06-0126 DO - 10.1158/1535-7163.MCT-06-0126 ID - Sørlie2006 ER - TY - JOUR AU - Hatzis, C. AU - Pusztai, L. AU - Valero, V. AU - Booser, D. J. AU - Esserman, L. AU - Lluch, A. PY - 2011 DA - 2011// TI - A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer JO - JAMA VL - 305 UR - https://doi.org/10.1001/jama.2011.593 DO - 10.1001/jama.2011.593 ID - Hatzis2011 ER - TY - JOUR AU - Kuerer, H. M. AU - Newman, L. A. AU - Smith, T. L. AU - Ames, F. C. AU - Hunt, K. K. AU - Dhingra, K. PY - 1999 DA - 1999// TI - Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy JO - J Clin Oncol VL - 17 ID - Kuerer1999 ER - TY - JOUR AU - Jones, R. L. AU - Salter, J. AU - A’Hern, R. AU - Nerurkar, A. AU - Parton, M. AU - Reis-Filho, J. S. PY - 2009 DA - 2009// TI - The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer JO - Breast Cancer Res Treat VL - 116 UR - https://doi.org/10.1007/s10549-008-0081-7 DO - 10.1007/s10549-008-0081-7 ID - Jones2009 ER - TY - JOUR AU - Hudis, C. A. AU - Barlow, W. E. AU - Costantino, J. P. AU - Gray, R. J. AU - Pritchard, K. I. AU - Chapman, J. -. A. W. PY - 2007 DA - 2007// TI - Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP System JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.10.3523 DO - 10.1200/JCO.2006.10.3523 ID - Hudis2007 ER - TY - JOUR AU - Magbanua, M. J. AU - Roy, R. AU - Sosa, E. V. AU - Weinberg, V. AU - Federman, S. AU - Mattie, M. D. PY - 2011 DA - 2011// TI - Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0024004 DO - 10.1371/journal.pone.0024004 ID - Magbanua2011 ER - TY - JOUR AU - Haqq, C. AU - Nosrati, M. AU - Sudilovsky, D. AU - Crothers, J. AU - Khodabakhsh, D. AU - Pulliam, B. L. PY - 2005 DA - 2005// TI - The gene expression signatures of melanoma progression JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0501564102 DO - 10.1073/pnas.0501564102 ID - Haqq2005 ER - TY - JOUR AU - Diehn, M. AU - Sherlock, G. AU - Binkley, G. AU - Jin, H. AU - Matese, J. C. AU - Hernandez-Boussard, T. PY - 2003 DA - 2003// TI - SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data JO - Nucleic Acids Res VL - 31 UR - https://doi.org/10.1093/nar/gkg014 DO - 10.1093/nar/gkg014 ID - Diehn2003 ER - TY - JOUR AU - Karolchik, D. AU - Kuhn, R. M. AU - Baertsch, R. AU - Barber, G. P. AU - Clawson, H. AU - Diekhans, M. PY - 2008 DA - 2008// TI - The UCSC Genome Browser Database: 2008 update JO - Nucleic Acids Res VL - 36 UR - https://doi.org/10.1093/nar/gkm966 DO - 10.1093/nar/gkm966 ID - Karolchik2008 ER - TY - JOUR AU - Parker, J. S. AU - Mullins, M. AU - Cheang, M. C. AU - Leung, S. AU - Voduc, D. AU - Vickery, T. PY - 2009 DA - 2009// TI - Supervised risk predictor of breast cancer based on intrinsic subtypes JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.1370 DO - 10.1200/JCO.2008.18.1370 ID - Parker2009 ER - TY - JOUR AU - Dressman, H. K. AU - Hans, C. AU - Bild, A. AU - Olson, J. A. AU - Rosen, E. AU - Marcom, P. K. PY - 2006 DA - 2006// TI - Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-1447 DO - 10.1158/1078-0432.CCR-05-1447 ID - Dressman2006 ER - TY - JOUR AU - Kolacinska, A. AU - Fendler, W. AU - Szemraj, J. AU - Szymanska, B. AU - Borowska-Garganisz, E. AU - Nowik, M. PY - 2012 DA - 2012// TI - Gene expression and pathologic response to neoadjuvant chemotherapy in breast cancer JO - Mol Biol Rep VL - 39 UR - https://doi.org/10.1007/s11033-012-1576-1 DO - 10.1007/s11033-012-1576-1 ID - Kolacinska2012 ER - TY - JOUR AU - Lin, Y. AU - Lin, S. AU - Watson, M. AU - Trinkaus, K. M. AU - Kuo, S. AU - Naughton, M. J. PY - 2010 DA - 2010// TI - A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy JO - Breast Cancer Res Treat VL - 123 UR - https://doi.org/10.1007/s10549-009-0664-y DO - 10.1007/s10549-009-0664-y ID - Lin2010 ER - TY - JOUR AU - Balko, J. M. AU - Cook, R. S. AU - Vaught, D. B. AU - Kuba, M. G. AU - Miller, T. W. AU - Bhola, N. E. PY - 2012 DA - 2012// TI - Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance JO - Nat Med VL - 18 UR - https://doi.org/10.1038/nm.2795 DO - 10.1038/nm.2795 ID - Balko2012 ER - TY - JOUR AU - Ayers, M. AU - Symmans, W. F. AU - Stec, J. AU - Damokosh, A. I. AU - Clark, E. AU - Hess, K. PY - 2004 DA - 2004// TI - Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.05.166 DO - 10.1200/JCO.2004.05.166 ID - Ayers2004 ER - TY - JOUR AU - Korde, L. A. AU - Lusa, L. AU - McShane, L. AU - Lebowitz, P. F. AU - Lukes, L. AU - Camphausen, K. PY - 2010 DA - 2010// TI - Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer JO - Breast Cancer Res Treat VL - 119 UR - https://doi.org/10.1007/s10549-009-0651-3 DO - 10.1007/s10549-009-0651-3 ID - Korde2010 ER - TY - JOUR AU - Chang, J. C. AU - Wooten, E. C. AU - Tsimelzon, A. AU - Hilsenbeck, S. G. AU - Gutierrez, M. C. AU - Elledge, R. PY - 2003 DA - 2003// TI - Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer JO - Lancet VL - 362 UR - https://doi.org/10.1016/S0140-6736(03)14023-8 DO - 10.1016/S0140-6736(03)14023-8 ID - Chang2003 ER - TY - JOUR AU - Buchholz, T. A. AU - Stivers, D. N. AU - Stec, J. AU - Ayers, M. AU - Clark, E. AU - Bolt, A. PY - 2002 DA - 2002// TI - Global gene expression changes during neoadjuvant chemotherapy for human breast cancer JO - Cancer J VL - 8 UR - https://doi.org/10.1097/00130404-200211000-00010 DO - 10.1097/00130404-200211000-00010 ID - Buchholz2002 ER - TY - JOUR AU - Modlich, O. AU - Prisack, H. B. AU - Munnes, M. AU - Audretsch, W. AU - Bojar, H. PY - 2004 DA - 2004// TI - Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer disease JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-04-1031 DO - 10.1158/1078-0432.CCR-04-1031 ID - Modlich2004 ER - TY - JOUR AU - Beitsch, P. AU - Lotzova, E. AU - Hortobagyi, G. AU - Pollock, R. PY - 1994 DA - 1994// TI - Natural immunity in breast cancer patients during neoadjuvant chemotherapy and after surgery JO - Surg Oncol VL - 3 UR - https://doi.org/10.1016/0960-7404(94)90036-1 DO - 10.1016/0960-7404(94)90036-1 ID - Beitsch1994 ER - TY - JOUR AU - Vera-Ramirez, L. AU - Sanchez-Rovira, P. AU - Ramirez-Tortosa, C. L. AU - Quiles, J. L. AU - Ramirez-Tortosa, M. AU - Lorente, J. A. PY - 2013 DA - 2013// TI - Transcriptional shift identifies a set of genes driving breast cancer chemoresistance JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0053983 DO - 10.1371/journal.pone.0053983 ID - Vera-Ramirez2013 ER - TY - JOUR AU - Tsai, M. S. AU - Bogart, D. F. AU - Castañeda, J. M. AU - Li, P. AU - Lupu, R. PY - 2002 DA - 2002// TI - Cyr61 promotes breast tumorigenesis and cancer progression JO - Oncogene VL - 21 UR - https://doi.org/10.1038/sj.onc.1205682 DO - 10.1038/sj.onc.1205682 ID - Tsai2002 ER - TY - JOUR AU - Xie, D. AU - Miller, C. W. AU - O’Kelly, J. AU - Nakachi, K. AU - Sakashita, A. AU - Said, J. W. PY - 2001 DA - 2001// TI - Breast cancer: Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease JO - J Biol Chem VL - 276 ID - Xie2001 ER - TY - JOUR AU - Lin, M. T. AU - Chang, C. C. AU - Chen, S. T. AU - Chang, H. L. AU - Su, J. L. AU - Chau, Y. P. PY - 2004 DA - 2004// TI - Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-κB-dependent XIAP up-regulation JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M402305200 DO - 10.1074/jbc.M402305200 ID - Lin2004 ER - TY - JOUR AU - Lin, J. AU - Huo, R. AU - Wang, L. AU - Zhou, Z. AU - Sun, Y. AU - Shen, B. PY - 2012 DA - 2012// TI - A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo JO - Cancer Immunol Immunother VL - 61 UR - https://doi.org/10.1007/s00262-011-1135-y DO - 10.1007/s00262-011-1135-y ID - Lin2012 ER - TY - JOUR AU - Ryu, C. S. AU - Kwak, H. C. AU - Lee, K. S. AU - Kang, K. W. AU - Oh, S. J. AU - Lee, K. H. PY - 2011 DA - 2011// TI - Sulfur amino acid metabolism in doxorubicin-resistant breast cancer cells JO - Toxicol Appl Pharmacol VL - 255 UR - https://doi.org/10.1016/j.taap.2011.06.004 DO - 10.1016/j.taap.2011.06.004 ID - Ryu2011 ER - TY - JOUR AU - Visser, K. E. AU - Eichten, A. AU - Coussens, L. M. PY - 2006 DA - 2006// TI - Paradoxical roles of the immune system during cancer development JO - Nat Rev Cancer VL - 6 UR - https://doi.org/10.1038/nrc1782 DO - 10.1038/nrc1782 ID - Visser2006 ER - TY - JOUR AU - Callari, M. AU - Musella, V. AU - Buduo, E. AU - Sensi, M. AU - Miodini, P. AU - Dugo, M. PY - 2014 DA - 2014// TI - Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer JO - Mol Oncol VL - 8 UR - https://doi.org/10.1016/j.molonc.2014.04.010 DO - 10.1016/j.molonc.2014.04.010 ID - Callari2014 ER - TY - JOUR AU - Weichselbaum, R. R. AU - Ishwaran, H. AU - Yoon, T. AU - Nuyten, D. S. AU - Baker, S. W. AU - Khodarev, N. PY - 2008 DA - 2008// TI - An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0809242105 DO - 10.1073/pnas.0809242105 ID - Weichselbaum2008 ER - TY - JOUR AU - Wolf, D. M. AU - Lenburg, M. E. AU - Yau, C. AU - Boudreau, A. AU - van ’t Veer, L. J. PY - 2014 DA - 2014// TI - Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0088309 DO - 10.1371/journal.pone.0088309 ID - Wolf2014 ER - TY - JOUR AU - Hoadley, K. A. AU - Yau, C. AU - Wolf, D. M. AU - Cherniack, A. D. AU - Tamborero, D. AU - Ng, S. PY - 2014 DA - 2014// TI - Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin JO - Cell VL - 158 UR - https://doi.org/10.1016/j.cell.2014.06.049 DO - 10.1016/j.cell.2014.06.049 ID - Hoadley2014 ER - TY - JOUR AU - Barker, A. D. AU - Sigman, C. C. AU - Kelloff, G. J. AU - Hylton, N. M. AU - Berry, D. A. AU - Esserman, L. J. PY - 2009 DA - 2009// TI - I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy JO - Clin Pharmacol Ther VL - 86 UR - https://doi.org/10.1038/clpt.2009.68 DO - 10.1038/clpt.2009.68 ID - Barker2009 ER -